Nephros NEPH
NASDAQ NEPH
$4.47 -0.07 (-1.59%)
At close: Sep 11, 2026 · 4:00 PM EDT

Nephros (NEPH) EV to EBIT (2010 - 2026)

Nephros (NEPH) posted EV to EBIT of 28.09 for Q2 2026, down 90.37% on a QoQ basis from 291.71 in Q1 2026, and down 81.8% year-over-year from 154.36 in Q2 2025.

Analysis

Nephros (NEPH) EV to EBIT (2010 - 2026) Analysis & Trends

Nephros has reported EV to EBIT for 17 years, with the latest figure at 28.09 in Q2 2026.

  • On a quarterly basis, EV to EBIT fell 81.8% year-over-year to 28.09 in Q2 2026; TTM through Jun 2026 was 20.75, a 27.53% decrease from a year earlier, with the FY2025 full-year figure at 40.61, down 97.92% from the prior year.
  • EV to EBIT was 28.09 for Q2 2026 at Nephros, down from 291.71 in the prior quarter.
  • The five-year high for EV to EBIT was 2585.78 in Q4 2025, with the low at 97.29 in Q1 2024.
  • Average EV to EBIT over 5 years is 164.35, with a median of 11.75 recorded in 2022.
  • The sharpest annual moves came in 2023 and 2025: EV to EBIT tumbled 688.89% in 2023, then jumped 6881.63% in 2025.
  • Over 5 years, EV to EBIT stood at 16.69 in 2022, then tumbled by 196.96% to 49.57 in 2023, then jumped by 174.71% to 37.04 in 2024, then surged by 6881.63% to 2585.78 in 2025, then tumbled by 98.91% to 28.09 in 2026.
  • The last three EV to EBIT figures came in at 28.09 (Q2 2026), 291.71 (Q1 2026), and 2585.78 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 178.01 Bn 172.41 Bn 7.27 Bn
2 Intuitive Surgical 131.29 Bn 126.08 Bn 1.96 Bn
3 Medtronic 116.38 Bn 107.56 Bn 6.34 Bn
4 Stryker 106.01 Bn 102.53 Bn 4.50 Bn
5 Boston Scientific 63.40 Bn 62.86 Bn 3.85 Bn
6 Edwards Lifesciences 48.89 Bn 44.64 Bn 1.35 Bn
7 Alcon 32.59 Bn 31.13 Bn 1.68 Bn
8 Dexcom 31.84 Bn 29.89 Bn 830.00 Mn
9 Steris 20.61 Bn 20.13 Bn 684.20 Mn
10 Nephros 48.31 Mn 43.62 Mn 4.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 28.09
Mar 31, 2026 291.71
Dec 31, 2025 2,585.78
Sep 30, 2025 143.61
Jun 30, 2025 154.36
Mar 31, 2025 25.00
Dec 31, 2024 37.04
Sep 30, 2024 75.60
Jun 30, 2024 -60.47
Mar 31, 2024 -97.29
Dec 31, 2023 -49.57
Sep 30, 2023 -53.67
Jun 30, 2023 -28.03
Mar 31, 2023 -24.13
Dec 31, 2022 -16.69
Sep 30, 2022 -6.80
Jun 30, 2022 -18.27
Mar 31, 2022 -27.94
Dec 31, 2021 -78.51
Sep 30, 2021 -106.54